VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > New Press Release - VENTRIPOINT and ASCEND Cardiovasc

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon Dec 20, 2024 10:52am

33 Views

Post# 36372177

RE: RE:RE:New Press Release - VENTRIPOINT and ASCEND Cardiovasc

Remember good post @cardinalSeattle cardio just called the tech a must Standard of care at large conference. Mayo clinic now buying. Europe committing . The tech is fantastic and getting better and likely serves wider product lines like valves .Interesting Mayo Clinic Transcatheter aortic valve replacement (TAVR) https://www.mayoclinic.org/tests-procedures/transcatheter-aortic-valve-replacement/about/pac-20384698

& I think Dr. Adams the visionary with Ventripoint is giving us a in the long run for our patience and trust with Ventripoint.Remember The BEST automation and analysis of the PLANET GEN3EHO On Ascend website https://ascendcv.com/ direct entry into 1500 major US centers.& Now CardioLogic Ltd: Introducing Ventripoint 4.0. Hugh is lining this up perfectly . 1 Mayo Clinic #1 cardiac center in the entire world. Remember 24-11-2023 low = 0.135 & 08-01-2024 high = 0.36 I also think that Dr. Adams the visionary with Ventripoint will silence the denigrators with FDA V4.0 & Sales very soon... 5 trading days before January 2, 2025#vpt,